| Cachexia index in predicting outcomes among patients receiving immune checkpoint inhibitor treatment for metastatic renal cell carcinoma V Aslan, ACK Kılıç, O Sütcüoğlu, E Eraslan, A Bayrak, B Öksüzoğlu, ... Urologic Oncology: Seminars and Original Investigations 40 (11), 494. e1-494 …, 2022 | 7 | 2022 |
| Predictive and prognostic effect of ABO blood group on immune checkpoint inhibitors Y Ergun, SA Esen, M Bardakci, G Ucar, Z Kalkan, Z Urakci, E Seyran, ... Cancer Biomarkers 34 (2), 329-336, 2022 | 4 | 2022 |
| The role of spleen volume change in predicting immunotherapy response in metastatic renal cell carcinoma V Aslan, AC Karabörk Kılıç, A Özet, A Üner, N Günel, O Yazıcı, G Savaş, ... BMC cancer 23 (1), 1045, 2023 | 3 | 2023 |
| Current status of biosimilars in Turkey: a survey among medical oncologists F Gürler, DD Kasım, B Kurt İnci, O Sütçüoğlu, O Ünsal, V Aslan, G Tahtacı, ... Journal of Oncology Pharmacy Practice 28 (7), 1516-1523, 2022 | 3 | 2022 |
| Abscobal effect of balstilimab and zalifrelimab combination as second-line treatment for advanced cervical cancer V Aslan, O Sütcüoğlu, A Özet, N Özdemir, O Yazici Journal of Clinical Oncology 40 (19), 2022 | 1 | 2022 |
| JOURNAL of ONCOLOGICAL SCIENCES BK İNCİ, F GÜRLER, O SÜTCÜOĞLU, O ÜNSAL, V ASLAN, O YAZICI, ... Journal of Oncological Sciences 10 (1), 32-8, 2024 | | 2024 |
| Combination therapies in non-clear-cell renal cell carcinoma V Aslan, N Özdemir, A Özet The Lancet Oncology 24 (10), e401, 2023 | | 2023 |
| Increased Tumor Mutation Burden Levels and Sensitivity of Non–Small Cell Lung Cancer to PD-L1 Blockade X Zhang, L Zhang JAMA oncology 9 (4), 569-570, 2023 | | 2023 |
| Investigation of Endocrine Disease Frequency in Dyslipidemia V Aslan, G AKÇAY Archives of Basic and Clinical Research 5 (1), 2023 | | 2023 |
| KANSER NASIL OLUŞUR? KANSER TEDAVİSİNDE GÜNCEL TEDAVİ SEÇENEKLERİ NELERDİR? V Aslan Nobel Yayın Dağıtım, 2022 | | 2022 |
| A Case of Giant Posterior Mediastinal Mass: Gastrointestinal Stromal Tumor Developed in Neurofibromatosis Type 1 Patient. V ASLAN, F Gürler | | 2021 |
| Use of Eltrombopag in Immune Thrombocytopenia in Turkey D Çekdemir, F Ozdemirkiran, S Guvenc, A Eser, V Ozkocaman, HH Sahin, ... Pergamon-Elsevier Science Ltd, 2016 | | 2016 |
| The Reallife Comparison of FOLFIRINOX vs Gemcitabine Platinum Combination as a First-Line Treatment in Patients with Pancreatic Carcinoma BK İNCİ, F Gürler, O Sütcüoğlu, O Ünsal, V Aslan, O YAZICI, A ÜNER, ... | | |
| Metastatik Renal Hücreli Karsinomda Nivolumab ile Dalak Volümü Arasındaki İlişkinin Prognostik Önemi V Aslan | | |
| PARANEOPLASTİK POLİNÖROPATİ KLİNİĞİ İLEBAŞVURAN EXTRAGONADAL GERM HÜCRELİ TÜMÖROLGUSU. V ASLAN, O ÜNSAL, N RUSTEMOVA, O SÜTCÜOĞLU, B KURT İNCİ, ... | | |
| TIBBİ ONKOLOJI SERVİS YATIŞ SÜRESİNİ ÖNGÖRMEDE HEMOGLOBİN, ALBÜMİN, LENFOSİT VE TROMBOSİT KOMBİNASYONUNUN DEĞERİ O Sütcüoğlu, O Ünsal, V Aslan, B Ulaş Kahya, G Tahtacı, N Özdemir, ... | | |
| Yeni Bir Tedavi Modeli: İleri Evre Akciğer Adenokarsinomlu Bir Olguda Nivolumab Tedavisinin Aralıklı Kullanımı O ÜNSAL, V ASLAN, N RÜSTEMOVA, O SÜTCÜOĞLU, B KURT İNCİ, ... | | |
| SARKOPENİ VE OBEZİTENİN METASTATİK RCC HASTALARINDA İMMÜNOTERAPİ TEDAVİSİNİN ETKİNLİĞİNİ ÖNGÖRMEDEKİ ROLÜ V Aslan, O Sütcüoğlu, O Ünsal, N Özdemir, A Üner, G Tahtacı, N Günel, ... | | |
| RETROSPECTIVE ANALYSIS OF SORAFENIBTREATMENT IN ADVANCED-STAGEHEPATOCELLULAR CARCINOMA: A SINGLECENTER EXPERIENCE O ÜNSAL, V ASLAN, O YAZICI, A ÜNER, A ÖZET, N ÖZDEMİR | | |
